...Business: Cardiovascular, Cancer, Neurology Hired: David Ichikawa as SVP of business development, formerly CBO of Sagres Discovery...

...amortization expense related to the acquisitions of PathoGenesis ; Chiron Behring; Pulmopharm; PowderJect ; and Sagres...

...Although Chiron Corp. 's acquisition of Sagres Discovery Inc. doesn't remedy its thin clinical pipeline in cancer...
...the deal lays the foundation for a renewable internal source of oncology compounds. In addition, Sagres'...
...companies that use expression data to infer whether a gene may be a good target. Sagres'...

...CHIR acquired cancer target company Sagres for an undisclosed sum. Sagres uses its Oncogenome high throughput...
...XOMA, Berkeley, Calif.) to develop antibodies against targets from CHIR. Chiron Corp. (CHIR), Emeryville, Calif. Sagres Discovery...

...David Ferrick as VP of biology and clinical applications, formerly CEO and a director at Sagres Discovery...

...CHIR acquired cancer target company Sagres (Davis, Calif.) for an undisclosed sum. Sagres is using its...

...biology at the Scripps Research Institute, as chairman; Ali Fattaey, SVP of discovery research at Sagres...

...state. Such is the obstacle in comparing cancerous and healthy tissue. To solve that problem, Sagres Discovery...
...mutagenesis using a retrovirus to identify causative cancer genes - and made it high throughput. Sagres'...
...Sagres expects to retain the MemRx staff and maintain the research operation in San Diego. Sagres...

...Sagres will acquire protein structure-based drug discovery company MemRx. The equity-based deal combines Sagres' Oncogenome collection...
...determining the structures of membrane-bound protein targets, including G protein-coupled receptors (GPCRs) and ion channels. Sagres...
...staff and maintain the research operation in San Diego. MemRx Corp. , San Diego, Calif. Sagres Discovery...